SANTA CLARA, Calif., Oct. 31 /PRNewswire/ -- Bacchus Vascular Inc., a leading provider of innovative medical devices used by interventional radiologists and vascular surgeons for the minimally invasive treatment of deep vein thrombosis (DVT) and other peripheral vascular disease, announced today that it has named Dennis Rosenberg to the position of Vice President of Marketing.
Mr. Rosenberg has over 25 years experience in medical device and consumer marketing and sales. Most recently he served as Vice President of Marketing and International Sales for VNUS Medical Technologies from 2005 until June, 2007. From 1999 to 2005 he owned and operated a marketing communications consultancy, Metaphor Media, and from 2002 to 2004 concurrently served as Chief Marketing Officer at Acueity, Inc., a micro-endoscopy medical device company. Prior to that, he was co-founder and VP of Marketing and Sales for MD DataDirect, an internet medical information company, and VP and GM of Randomsoft, the software distribution division of Random House. He was also co-founder and VP, Marketing and Sales of Eclipse Surgical Technologies, a medical laser company, and co-founder and VP, Marketing and Sales of Atlantis Catheter Company, a cardiovascular device company.
“Dennis Rosenberg has a broad background in marketing, both inside and outside the medical device field,” said Scott Cramer, President and CEO of Bacchus Vascular. “He brings a wealth of relevant knowledge and experience in device marketing and physician practice building programs to Bacchus Vascular, and we are pleased to have his leadership in our marketing efforts.”
Mr. Rosenberg studied film and television production as well as computer programming at New York University, computer graphics at University of California Santa Cruz and graphic design at The New School in New York.
About Bacchus Vascular
Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from DVT and other occlusive vascular diseases have been treated worldwide to date using the company’s Trellis(R) Peripheral Infusion System and other products.
For more information, visit http://www.bacchusvascular.com.
CONTACT: Scott Cramer, President & CEO of Bacchus Vascular Inc.,
+1-408-980-8300 ext. 217, scramer@bacchusvascular.com
Web site: http://www.bacchusvascular.com/
